SPRY4 and breast carcinoma: Shi et al. have reported that an increased expression of SPRY4-IT1 is associated with a larger tumor size and later stage of tumor development in breast cancer patients and that a SPRY4-IT1 knockdown leads to suppressed cell proliferation and induced apoptosis in breast cancer cells.